Vor Biopharma Q3 Loss Narrows

MT newswire2026/10/30 12:42

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

08:42 AM EDT, 10/30/2026 (MT Newswires) -- Vor Biopharma (VOR) reported a Q3 loss Friday of $86.7 million, narrowing from a loss of $812.7 million a year earlier. Analysts polled by FactSet expected a loss of $48.2 million. As of Sept. 30, the company said it had $481.6 million in cash, cash equivalents and marketable securities, which it expects to fund operations into early 2029.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The Manufacturing Purchasing Managers' Index (PMI) released by the Institute for Supply Management (ISM) in the United States rose by 1 point in October to reach 55.5, marking the second highest reading in more than four years and exceeding the market expectation of 54.7. The production index recorded its best performance since the end of 2021, while the new orders index, a key indicator of demand, also reached its highest level since July.

华尔街见闻•2026/11/02 18:26

BUZZ-Choice Hotels raises fiscal 2026 guidance after third-quarter results exceed expectations

路透社•2026/11/02 17:21